White cell toxicity: A predictive marker for survival after adjuvant and neoadjuvant chemotherapy for breast cancer?

被引：0
|
作者：
Pandha, HS [1 ]
Ashley, S [1 ]
Smith, IE [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, Sutton SM2 5PT, Surrey, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
26
引用
下载
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Predictive factors associated with invasive lobular breast cancer after neoadjuvant chemotherapy
    Julian, T. B.
    Anderson, S.
    Fourchotte, V.
    Zieger, S.
    Mamounas, E.
    Bear, H.
    Costantino, J.
    Wolmark, N.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 17 - 17
  • [32] The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer
    Pieper, Willi
    Ignatov, Atanas
    Kalinski, Thomas
    Haybaeck, Johannes
    Czapiewski, Piotr
    Nass, Norbert
    CANCER BIOMARKERS, 2021, 32 (02) : 161 - 173
  • [33] Predictive markers of response to neoadjuvant chemotherapy in breast cancer
    Tewari, Mallika
    Krishnamurthy, Arvind
    Shukla, Hari S.
    SURGICAL ONCOLOGY-OXFORD, 2008, 17 (04): : 301 - 311
  • [34] Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy
    Fuksa, L.
    Micuda, S.
    Grim, J.
    Ryska, A.
    Hornychova, H.
    CANCER INVESTIGATION, 2012, 30 (09) : 663 - 678
  • [35] Adjuvant Chemotherapy after neoadjuvant Chemoradiotherapy for Rectal cancer
    Reibetanz, J.
    Germer, C. -T.
    CHIRURG, 2014, 85 (06): : 544 - 544
  • [36] A pilot study of adjuvant bevacizumab and chemotherapy after neoadjuvant chemotherapy for high-risk breast cancer
    Mayer, E. L.
    Miller, K. D.
    Rugo, H. S.
    Peppercorn, J. M.
    Carey, L. A.
    Ryabin, N.
    Josephs, K.
    Winer, E. P.
    Burstein, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Concurrent Chemotherapy With Adjuvant Radiation for Breast Cancer After Incomplete Response to Neoadjuvant Chemotherapy: Safety and Outcomes
    Mullen, Thomas D.
    Chang, Amy E.
    Linden, Hannah M.
    Kim, Janice N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E18 - E18
  • [38] Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
    Symmans, W. Fraser
    Peintinger, Florentia
    Hatzis, Christos
    Rajan, Radhika
    Kuerer, Henry
    Valero, Vicente
    Assad, Lina
    Poniecka, Anna
    Hennessy, Bryan
    Green, Marjorie
    Buzdar, Aman U.
    Singletary, S. Eva
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) : 4414 - 4422
  • [39] In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
    Ladoire, Sylvain
    Mignot, Gregoire
    Dabakuyo, Sandrine
    Arnould, Laurent
    Apetoh, Lionel
    Rebe, Cedric
    Coudert, Bruno
    Martin, Francois
    Bizollon, Marie Helene
    Vanoli, Andre
    Coutant, Charles
    Fumoleau, Pierre
    Bonnetain, Franck
    Ghiringhelli, Francois
    JOURNAL OF PATHOLOGY, 2011, 224 (03): : 389 - 400
  • [40] Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes
    Al-Masri, Mahmoud
    Aljalabneh, Basim
    Al-Najjar, Hani
    Al-Shamaileh, Tamador
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 7 - 13
12345